Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 69097-210

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 69097-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4ba582f2 65bd 44e0 9930 1f4b40025133 01)

Chemical structure diagram of the active ingredient efavirenz, showing its molecular configuration with labeled atoms including chlorine, fluorine, and distinctive chemical groups.*

FDA Label Image

Image (4ba582f2 65bd 44e0 9930 1f4b40025133 02)

Chemical structure diagram depicting the molecular structure of an active pharmaceutical ingredient, likely one of the components of efavirenz, emtricitabine, and tenofovir disoproxil fumarate combination tablets. The structure features a fluorine atom and a fused ring system with nitrogen, oxygen, sulfur, and hydroxyl groups.*

FDA Label Image

Image (4ba582f2 65bd 44e0 9930 1f4b40025133 03)

Chemical structure diagram depicting the molecular arrangement of tenofovir disoproxil fumarate, one of the active ingredients in this drug combination.*

FDA Label Image

30s (4ba582f2 65bd 44e0 9930 1f4b40025133 04)

Label for efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets, film coated, strength 600 mg/200 mg/300 mg, supplied by Cipla USA Inc. The label includes dosage details, storage instructions, manufacturer information, a barcode, and a note about batch overprinting for serial number, expiry, and lot.*

FDA Label Image

Genvion (4ba582f2 65bd 44e0 9930 1f4b40025133 05)

Label for efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets, film-coated, containing 600 mg/200 mg/300 mg strengths. The label includes manufacturer details for Cipla USA Inc., dosage form as oral tablets, a barcode, and warnings for pharmacists regarding medicines that should not be taken with this combination. The package size is 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.